After his doctorate at University College London, Bjarke Abrahamsen packed
his bags and returned home to Denmark in 2008 for a postdoc at the University of
Copenhagen, which ranked second for international locations in our 7th Annual Best
places to Work for Postdocs survey. One of the things that drew him back, he says,
was a more fluid relationship between the university and industry than he
experienced in the United Kingdom. Groups at the University of Copenhagen routinely
collaborate with companies or do rotations in company labs, and researchers move
between industry and academic positions with ease. For that reason, "it wouldn't be
a disaster for me at all" to switch to a company or back again, he says.
Although there are no special support programs for postdocs, Abrahamsen says
he appreciates the informality—which may simply be a part of the Danish culture. "In
my group it's a very flat management structure." Abrahamsen works with associate
professor Anders Jensen on the basic molecular biology and pharmacology of glutamate
transporters. The absence of hierarchy "quickly makes you feel a valued part of the
university and not just hands to generate data for the lab, " says Abrahamsen.
According to Ulf Madsen, associate dean at the faculty of pharmaceutical
sciences, postdocs are drawn to the university because of the quality of the
science—which has improved in the last two years. In January 2007, the university
merged with two small universities in the city, the Danish University of
Pharmaceutical Sciences and Royal Veterinary and Agricultural University,
strengthening Copenhagen's offering in the life sciences by two large biology-based
faculties, or schools. In order to integrate the three universities, the
administration created 20 internal five year grants of $5 million (US) each to
stimulate interdisciplinary collaborations. As a result of these efforts, says
Madsen, the "research has become stronger."